Correlation Between Cogeco Communications and Rakovina Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cogeco Communications and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogeco Communications and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cogeco Communications and Rakovina Therapeutics, you can compare the effects of market volatilities on Cogeco Communications and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogeco Communications with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogeco Communications and Rakovina Therapeutics.

Diversification Opportunities for Cogeco Communications and Rakovina Therapeutics

-0.69

Correlation Coefficient

Cogeco Communications  Rakovina Therapeutics

Excellent diversification

The 3 months correlation between Cogeco and Rakovina is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cogeco Communications and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and Cogeco Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogeco Communications are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of Cogeco Communications i.e., Cogeco Communications and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between Cogeco Communications and Rakovina Therapeutics

Assuming the 90 days trading horizon Cogeco Communications is expected to generate 0.2 times more return on investment than Rakovina Therapeutics. However, Cogeco Communications is 5.02 times less risky than Rakovina Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Rakovina Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  6,553  in Cogeco Communications on December 21, 2024 and sell it today you would earn a total of  114.00  from holding Cogeco Communications or generate 1.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cogeco Communications  vs.  Rakovina Therapeutics

Cogeco Communications

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cogeco Communications are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Cogeco Communications is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Rakovina Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Rakovina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Cogeco Communications and Rakovina Therapeutics

The main advantage of trading using opposite Cogeco Communications and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogeco Communications position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.

The idea behind Cogeco Communications and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.